Copyright Reports & Markets. All rights reserved.

Global Substance Abuse Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Substance Abuse Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Opioid Addiction
      • 1.4.3 Tobacco/Nicotine Addiction
      • 1.4.4 Alcohol Dependence
    • 1.5 Market by Application
      • 1.5.1 Global Substance Abuse Therapeutics Market Share by Application (2014-2025)
      • 1.5.2 Hospital & Clinics
      • 1.5.3 Residential (non-hospital)
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Substance Abuse Therapeutics Market Size
    • 2.2 Substance Abuse Therapeutics Growth Trends by Regions
      • 2.2.1 Substance Abuse Therapeutics Market Size by Regions (2014-2025)
      • 2.2.2 Substance Abuse Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Substance Abuse Therapeutics Market Size by Manufacturers
      • 3.1.1 Global Substance Abuse Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Substance Abuse Therapeutics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Substance Abuse Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Substance Abuse Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Substance Abuse Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Substance Abuse Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Substance Abuse Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Substance Abuse Therapeutics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Substance Abuse Therapeutics Market Size (2014-2019)
    • 5.2 Substance Abuse Therapeutics Key Players in United States
    • 5.3 United States Substance Abuse Therapeutics Market Size by Type
    • 5.4 United States Substance Abuse Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Substance Abuse Therapeutics Market Size (2014-2019)
    • 6.2 Substance Abuse Therapeutics Key Players in Europe
    • 6.3 Europe Substance Abuse Therapeutics Market Size by Type
    • 6.4 Europe Substance Abuse Therapeutics Market Size by Application

    7 China

    • 7.1 China Substance Abuse Therapeutics Market Size (2014-2019)
    • 7.2 Substance Abuse Therapeutics Key Players in China
    • 7.3 China Substance Abuse Therapeutics Market Size by Type
    • 7.4 China Substance Abuse Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Substance Abuse Therapeutics Market Size (2014-2019)
    • 8.2 Substance Abuse Therapeutics Key Players in Japan
    • 8.3 Japan Substance Abuse Therapeutics Market Size by Type
    • 8.4 Japan Substance Abuse Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Substance Abuse Therapeutics Market Size (2014-2019)
    • 9.2 Substance Abuse Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Substance Abuse Therapeutics Market Size by Type
    • 9.4 Southeast Asia Substance Abuse Therapeutics Market Size by Application

    10 India

    • 10.1 India Substance Abuse Therapeutics Market Size (2014-2019)
    • 10.2 Substance Abuse Therapeutics Key Players in India
    • 10.3 India Substance Abuse Therapeutics Market Size by Type
    • 10.4 India Substance Abuse Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Substance Abuse Therapeutics Market Size (2014-2019)
    • 11.2 Substance Abuse Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Substance Abuse Therapeutics Market Size by Type
    • 11.4 Central & South America Substance Abuse Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 Indivior
      • 12.1.1 Indivior Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Substance Abuse Therapeutics Introduction
      • 12.1.4 Indivior Revenue in Substance Abuse Therapeutics Business (2014-2019)
      • 12.1.5 Indivior Recent Development
    • 12.2 Pfizer
      • 12.2.1 Pfizer Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Substance Abuse Therapeutics Introduction
      • 12.2.4 Pfizer Revenue in Substance Abuse Therapeutics Business (2014-2019)
      • 12.2.5 Pfizer Recent Development
    • 12.3 Alkermes
      • 12.3.1 Alkermes Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Substance Abuse Therapeutics Introduction
      • 12.3.4 Alkermes Revenue in Substance Abuse Therapeutics Business (2014-2019)
      • 12.3.5 Alkermes Recent Development
    • 12.4 Novartis
      • 12.4.1 Novartis Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Substance Abuse Therapeutics Introduction
      • 12.4.4 Novartis Revenue in Substance Abuse Therapeutics Business (2014-2019)
      • 12.4.5 Novartis Recent Development
    • 12.5 Mylan
      • 12.5.1 Mylan Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Substance Abuse Therapeutics Introduction
      • 12.5.4 Mylan Revenue in Substance Abuse Therapeutics Business (2014-2019)
      • 12.5.5 Mylan Recent Development
    • 12.6 Cipla
      • 12.6.1 Cipla Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Substance Abuse Therapeutics Introduction
      • 12.6.4 Cipla Revenue in Substance Abuse Therapeutics Business (2014-2019)
      • 12.6.5 Cipla Recent Development
    • 12.7 Glenmark
      • 12.7.1 Glenmark Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Substance Abuse Therapeutics Introduction
      • 12.7.4 Glenmark Revenue in Substance Abuse Therapeutics Business (2014-2019)
      • 12.7.5 Glenmark Recent Development
    • 12.8 Dr. Reddy's Laboratories
      • 12.8.1 Dr. Reddy's Laboratories Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Substance Abuse Therapeutics Introduction
      • 12.8.4 Dr. Reddy's Laboratories Revenue in Substance Abuse Therapeutics Business (2014-2019)
      • 12.8.5 Dr. Reddy's Laboratories Recent Development
    • 12.9 Teva Pharmaceutical
      • 12.9.1 Teva Pharmaceutical Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Substance Abuse Therapeutics Introduction
      • 12.9.4 Teva Pharmaceutical Revenue in Substance Abuse Therapeutics Business (2014-2019)
      • 12.9.5 Teva Pharmaceutical Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Substance Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of substance abuse. Some commonly used drug for treatment of substance abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
      In 2018, the global Substance Abuse Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Substance Abuse Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Substance Abuse Therapeutics development in United States, Europe and China.

      The key players covered in this study
      Indivior
      Pfizer
      Alkermes
      Novartis
      Mylan
      Cipla
      Glenmark
      Dr. Reddy's Laboratories
      Teva Pharmaceutical

      Market segment by Type, the product can be split into
      Opioid Addiction
      Tobacco/Nicotine Addiction
      Alcohol Dependence

      Market segment by Application, split into
      Hospital & Clinics
      Residential (non-hospital)

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Substance Abuse Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Substance Abuse Therapeutics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Substance Abuse Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now